TY - JOUR
T1 - Methodological Priorities for Patient Preferences Research
T2 - Stakeholder Input to the PREFER Public-Private Project
AU - Smith, Ian P
AU - DiSantostefano, Rachael L
AU - de Bekker-Grob, Esther W
AU - Levitan, Bennett
AU - Berlin, Conny
AU - Veldwijk, Jorien
AU - de Wit, G Ardine
N1 - Funding Information:
The PREFER project has received funding from the IMI 2 Joint Undertaking under grant agreement number 115966. This joint undertaking receives support from the EU’s Horizon 2020 Research and Innovation Program and the EFPIA.
Funding Information:
PREFER is a 5-year project, funded jointly by the Innovative Medicines Initiative (IMI) 2 (EU Horizon 2020) and the European pharmaceutical industry [represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA)]. PREFER aims to strengthen patient-centric decision making throughout the MPLC by developing evidence-based recommendations to fill the gaps in knowledge regarding the methodological aspects of patient preference studies.
PY - 2021/9
Y1 - 2021/9
UR - http://www.scopus.com/inward/record.url?scp=85102884432&partnerID=8YFLogxK
U2 - 10.1007/s40271-021-00502-6
DO - 10.1007/s40271-021-00502-6
M3 - Editorial
C2 - 33721265
SN - 1178-1653
VL - 14
SP - 449
EP - 453
JO - Patient-Patient centered outcomes research
JF - Patient-Patient centered outcomes research
IS - 5
ER -